| Repso |
Human |
leflunomide |
leflunomide |
EMEA/H/C/001222 |
Teva B.V. |
2011/03/14
|
Withdrawn |
| Leflunomide Teva |
Human |
leflunomide |
leflunomide |
EMEA/H/C/002356 |
Teva Pharma B.V. |
2011/03/10
|
Lapsed |
| Ifirmacombi |
Human |
irbesartan;hydrochlorothiazide |
irbesartan;hydrochlorothiazide |
EMEA/H/C/002302 |
Krka, d.d., Novo mesto |
2011/03/04
|
Authorised |
| Xeplion |
Human |
paliperidone |
paliperidone palmitate |
EMEA/H/C/002105 |
Janssen-Cilag International N.V. |
2011/03/04
|
Authorised |
| Pumarix |
Human |
pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) |
pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) |
EMEA/H/C/001212 |
GlaxoSmithKline Biologicals S.A. |
2011/03/04
|
Withdrawn |
| Lamivudine/Zidovudine Teva |
Human |
lamivudine;zidovudine |
lamivudine;zidovudine |
EMEA/H/C/001236 |
Teva Pharma B.V. |
2011/02/28
|
Withdrawn |
| Xiapex |
Human |
collagenase Clostridium histolyticum |
collagenase Clostridium histolyticum |
EMEA/H/C/002048 |
Swedish Orphan Biovitrum AB |
2011/02/28
|
Withdrawn |
| Libertek |
Human |
roflumilast |
roflumilast |
EMEA/H/C/002399 |
AstraZeneca AB |
2011/02/28
|
Withdrawn |
| Daliresp |
Human |
roflumilast |
roflumilast |
EMEA/H/C/002398 |
AstraZeneca AB |
2011/02/28
|
Withdrawn |
| Esbriet |
Human |
pirfenidone |
Pirfenidone |
EMEA/H/C/002154 |
Roche Registration GmbH |
2011/02/27
|
Authorised |
| Entacapone Teva |
Human |
entacapone |
entacapone |
EMEA/H/C/002075 |
Teva Pharma B.V. |
2011/02/18
|
Authorised |
| Comfortis |
Veterinary |
spinosad |
spinosad |
EMEA/V/C/002233 |
Elanco GmbH |
2011/02/11
|
Withdrawn |
| Fluenz |
Human |
influenza vaccine (live attenuated, nasal) |
reassortant influenza virus (live attenuated) of the following strains:A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain |
EMEA/H/C/001101 |
MedImmune LLC |
2011/01/27
|
Withdrawn |
| Iasibon |
Human |
ibandronic acid |
ibandronic acid |
EMEA/H/C/002025 |
Pharmathen S.A. |
2011/01/21
|
Authorised |
| Docetaxel Teva Pharma |
Human |
docetaxel |
docetaxel |
EMEA/H/C/002032 |
Teva Pharma B.V. |
2011/01/21
|
Lapsed |
| Potactasol |
Human |
topotecan |
topotecan |
EMEA/H/C/002282 |
Actavis Group PTC ehf |
2011/01/06
|
Authorised |
| BTVPUR AlSap 1 |
Veterinary |
bluetongue-virus serotype-1 antigen |
bluetongue-virus serotype-1 antigen |
EMEA/V/C/002230 |
Merial |
2010/12/17
|
Withdrawn |
| Brilique |
Human |
ticagrelor |
ticagrelor |
EMEA/H/C/001241 |
AstraZeneca AB |
2010/12/03
|
Authorised |
| Possia |
Human |
ticagrelor |
ticagrelor |
EMEA/H/C/002303 |
AstraZeneca AB |
2010/12/03
|
Withdrawn |
| Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics |
Human |
prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) |
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/Viet Nam/1194/2004 (H5N1) |
EMEA/H/C/002269 |
Novartis Vaccines and Diagnostics S.r.l. |
2010/11/29
|
Expired |